@AASLDtweets dr. Garcia-Tsao: antibiotic prophylaxis makes sense in the setting of prior episode of SBP but no clear survival benefit #livermtg18
December 3, 2024 at 5:12 AM
@AASLDtweets dr. Garcia-Tsao: antibiotic prophylaxis makes sense in the setting of prior episode of SBP but no clear survival benefit #livermtg18
Bluesky's Top 10 Trending Words from the Past 10 Minutes:
️⚠️💨7 - jameis
️⚠️💨4 - winston
️⚠️💨4 - broncos
️⚠️💨1 - jeudy
️⚠️💨1 - ukraine
️⚠️💨1 - browns
️⚠️💨1 - pardoning
️⚠️💨1 - yards
️⚠️💨1 - gaza
10th - pardon
(tap/click to see all posts on Bluesky featuring that word!)
#ListenToBlackVoices
December 3, 2024 at 5:01 AM
@EASLedu @EASLnews a fond farewell to all from one of my favorite Paris landmarks. #ilc2018 was a tremendous success. Hope to see you @AASLDtweets #LiverMtg18 in San Francisco in the fall and #ilc2019 in Vienna next year
December 3, 2024 at 5:33 AM
@EASLedu @EASLnews a fond farewell to all from one of my favorite Paris landmarks. #ilc2018 was a tremendous success. Hope to see you @AASLDtweets #LiverMtg18 in San Francisco in the fall and #ilc2019 in Vienna next year
@AASLDtweets looking forward to another successful #LiverMtg18 #liversnaps makes a come@back this year so get your cams ready!
December 3, 2024 at 5:28 AM
@AASLDtweets looking forward to another successful #LiverMtg18 #liversnaps makes a come@back this year so get your cams ready!
Registration for #LiverMtg18 opens @2pm. Location is MOSCONE SOUTH not west as in previous years ...
December 3, 2024 at 5:28 AM
Registration for #LiverMtg18 opens @2pm. Location is MOSCONE SOUTH not west as in previous years ...
@AASLDtweets if walking down 4th from the Marriott Marquis, take a left on Howard past construction and the overpass bridge then cross to Moscone South for #LiverMtg18 registration
December 3, 2024 at 5:28 AM
@AASLDtweets if walking down 4th from the Marriott Marquis, take a left on Howard past construction and the overpass bridge then cross to Moscone South for #LiverMtg18 registration
@AASLDtweets most #LiverMtg18 events will take place at Moscone south with some happening across the street at Moscone north which will be accessible through the south lower level escalators due to construction
December 3, 2024 at 5:28 AM
@AASLDtweets most #LiverMtg18 events will take place at Moscone south with some happening across the street at Moscone north which will be accessible through the south lower level escalators due to construction
@AASLDtweets Million dollar view of #SanFrancisco at the annual @CLDFoundation reception for #LiverMtg18 attendees #LiverSnaps
December 3, 2024 at 5:28 AM
@AASLDtweets Million dollar view of #SanFrancisco at the annual @CLDFoundation reception for #LiverMtg18 attendees #LiverSnaps
@AASLDtweets The transplant course will explore whether near universal cure of #HCV and other advances will allow expansion of organ availability for liver cancers. Starts 8am/rm 157/160 #LiverMtg18
December 3, 2024 at 5:28 AM
@AASLDtweets The transplant course will explore whether near universal cure of #HCV and other advances will allow expansion of organ availability for liver cancers. Starts 8am/rm 157/160 #LiverMtg18
@AASLDtweets dr therault @UCSFTransplantS highlights the BE3a score which may predict which cured #HCV patients are highly likely to be delisted due to improvement. #LiverMtg18
December 3, 2024 at 5:28 AM
@AASLDtweets dr therault @UCSFTransplantS highlights the BE3a score which may predict which cured #HCV patients are highly likely to be delisted due to improvement. #LiverMtg18
@AASLDtweets dr therault: more cured #HCVref="/hashtag/HCV" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#HCV pts, no retransplants for recurrent HCV and use of #HCV infected organs means more available organs. #LiverMtg18
December 3, 2024 at 5:28 AM
@AASLDtweets dr therault: more cured #HCVref="/hashtag/HCV" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#HCV pts, no retransplants for recurrent HCV and use of #HCV infected organs means more available organs. #LiverMtg18
@AASLDtweets My take on the BE3a score which predicts removal from the list: I cannot think of a single listed patient I see who would score highly. Useful but not widely applicable #LiverMtg18
December 3, 2024 at 5:23 AM
@AASLDtweets My take on the BE3a score which predicts removal from the list: I cannot think of a single listed patient I see who would score highly. Useful but not widely applicable #LiverMtg18
@AASLDtweets dr Cortes: hypothermic and normothermic perfusion very promising to expand DCD pool. Less discard rates, biliary issues and primary non function #LiverMtg18
December 3, 2024 at 5:23 AM
@AASLDtweets dr Cortes: hypothermic and normothermic perfusion very promising to expand DCD pool. Less discard rates, biliary issues and primary non function #LiverMtg18
@AASLDtweets dr strasser: new UK organ allocation system uses computerized algorithm to match organ with recipient most likely to benefit. Certainly news to me and very progressive by US standards #LiverMtg18
December 3, 2024 at 5:23 AM
@AASLDtweets dr strasser: new UK organ allocation system uses computerized algorithm to match organ with recipient most likely to benefit. Certainly news to me and very progressive by US standards #LiverMtg18
@AASLDtweets Dr strasser: artificial neural networks may help optimize donor-recipient matching process. Of course this process is currently marginally about clinical science and mostly about policy #LiverMtg18
December 3, 2024 at 5:22 AM
@AASLDtweets Dr strasser: artificial neural networks may help optimize donor-recipient matching process. Of course this process is currently marginally about clinical science and mostly about policy #LiverMtg18
@AASLDtweets Strong feelings for and against use of DCD organs. Center experience also highlighted. In fairness, this is an option to address an overwhelming need #LiverMtg18
December 3, 2024 at 5:22 AM
@AASLDtweets Strong feelings for and against use of DCD organs. Center experience also highlighted. In fairness, this is an option to address an overwhelming need #LiverMtg18
@AASLDtweets dr therault: #HCV pos donors in neg recipients likely a good idea but needs to be studied and pursued in the context of a protocol with full informed consent #LiverMtg18
December 3, 2024 at 5:22 AM
@AASLDtweets dr therault: #HCV pos donors in neg recipients likely a good idea but needs to be studied and pursued in the context of a protocol with full informed consent #LiverMtg18
Dr kulik @NorthwesternMed if beyond Milan criteria and high tumor markers (AFP, DCP) then high risk of recurrence post transplant #LiverMtg18
December 3, 2024 at 5:22 AM
Dr kulik @NorthwesternMed if beyond Milan criteria and high tumor markers (AFP, DCP) then high risk of recurrence post transplant #LiverMtg18
@AASLDtweets dr kulik: should there be a “ceiling” for who should undergo downstaging? Yes...but some patients with branch portal vein thrombosis may still be eligible #LiverMtg18
December 3, 2024 at 5:22 AM
@AASLDtweets dr kulik: should there be a “ceiling” for who should undergo downstaging? Yes...but some patients with branch portal vein thrombosis may still be eligible #LiverMtg18
@AASLDtweets Dr Kulik: all trials of combination locoregional therapy plus systemic therapy have failed to meet endpoints #LiverMtg18
December 3, 2024 at 5:22 AM
@AASLDtweets Dr Kulik: all trials of combination locoregional therapy plus systemic therapy have failed to meet endpoints #LiverMtg18
@AASLDtweets dr Mehta @UCSFTransplantS if Tumor is small and liver function good then resection not transplant is best. #LiverMtg18
December 3, 2024 at 5:17 AM
@AASLDtweets dr Mehta @UCSFTransplantS if Tumor is small and liver function good then resection not transplant is best. #LiverMtg18
@AASLDtweets Dr. Heimbach @MayoClinic prevalence of intrahepatic cholangiocarcinoma increasing while hilar is stable or dropping #livermtg18
December 3, 2024 at 5:17 AM
@AASLDtweets Dr. Heimbach @MayoClinic prevalence of intrahepatic cholangiocarcinoma increasing while hilar is stable or dropping #livermtg18
@AASLDtweets Dr. Heimbach: summary of @mayo hilar CCA Transplant experience: 69% 5 year survival in this very highly selected group. #PSC pts have higher survival #livermtg18
December 3, 2024 at 5:17 AM
@AASLDtweets Dr. Heimbach: summary of @mayo hilar CCA Transplant experience: 69% 5 year survival in this very highly selected group. #PSC pts have higher survival #livermtg18
@AASLDtweets Prof. Mazaffero: likelihood of neuroendocrine tumor to be cured with Tx is 44%. Time to cure is 5.1 years and survival of uncured is 1.7 years #livermtg18
December 3, 2024 at 5:17 AM
@AASLDtweets Prof. Mazaffero: likelihood of neuroendocrine tumor to be cured with Tx is 44%. Time to cure is 5.1 years and survival of uncured is 1.7 years #livermtg18
@AASLDtweets Prof Mazzaffero: liver transplant for metastatic NET can be done for cure or palliation. Stick to metastatic disease to liver only. 5 yr survival about 59% #livermtg18
December 3, 2024 at 5:17 AM
@AASLDtweets Prof Mazzaffero: liver transplant for metastatic NET can be done for cure or palliation. Stick to metastatic disease to liver only. 5 yr survival about 59% #livermtg18